You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Antibacterial agents active against Gram Negative Bacilli in phase I, II, or III clinical trials
|
|---|---|
| Published in |
Expert Opinion on Investigational Drugs, March 2024
|
| DOI | 10.1080/13543784.2024.2326028 |
| Pubmed ID | |
| Authors |
David L. Paterson |
X Demographics
The data shown below were collected from the profiles of 60 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | 12% |
| Australia | 3 | 5% |
| India | 3 | 5% |
| Malaysia | 3 | 5% |
| Colombia | 2 | 3% |
| Switzerland | 2 | 3% |
| United Kingdom | 2 | 3% |
| Ecuador | 1 | 2% |
| Philippines | 1 | 2% |
| Other | 8 | 13% |
| Unknown | 28 | 47% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 37 | 62% |
| Scientists | 11 | 18% |
| Practitioners (doctors, other healthcare professionals) | 9 | 15% |
| Science communicators (journalists, bloggers, editors) | 3 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 6 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 2 | 33% |
| Unspecified | 1 | 17% |
| Student > Ph. D. Student | 1 | 17% |
| Student > Master | 1 | 17% |
| Unknown | 1 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Unspecified | 1 | 17% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 17% |
| Immunology and Microbiology | 1 | 17% |
| Neuroscience | 1 | 17% |
| Medicine and Dentistry | 1 | 17% |
| Other | 0 | 0% |
| Unknown | 1 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 38. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 April 2024.
All research outputs
#1,101,518
of 25,898,387 outputs
Outputs from Expert Opinion on Investigational Drugs
#16
of 2,126 outputs
Outputs of similar age
#16,953
of 337,041 outputs
Outputs of similar age from Expert Opinion on Investigational Drugs
#1
of 11 outputs
Altmetric has tracked 25,898,387 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,126 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 337,041 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.